[HTML][HTML] Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum

S Ferré, LI Sarasola, C Quiroz, F Ciruela - Neuropharmacology, 2023 - Elsevier
Adenosine plays a very significant role in modulating striatal glutamatergic and
dopaminergic neurotransmission. In the present essay we first review the extensive …

Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants

S Ferré, AM Belcher, J Bonaventura, C Quiroz… - Frontiers in …, 2022 - frontiersin.org
The functional and pharmacological significance of the dopamine D4 receptor (D4R) has
remained the least well understood of all the dopamine receptor subtypes. Even more …

Sensory Aspects of Restless Legs Syndrome: clinical, neurophysiological and neuroimaging prospectives.

E Antelmi, MP Mogavero, G Lanza, SM Cartella… - Sleep Medicine …, 2024 - Elsevier
Summary Restless Legs Syndrome (RLS) is a complex sensorimotor disorder, classified
among the sleep-related movement disorders. Although sensory symptoms appear as key …

[HTML][HTML] Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets

FV Carvalho, HE Landis, B Getachew… - Advances in …, 2024 - ncbi.nlm.nih.gov
Parkinson's Disease (PD) is a progressive neurodegenerative disease characterized by loss
of dopaminergic neurons in substantia nigra pars compacta (SNpc). Iron (Fe)-dependent …

[HTML][HTML] Putative animal models of restless legs syndrome: A systematic review and evaluation of their face and construct validity

A Silvani, I Ghorayeb, M Manconi, Y Li, S Clemens - Neurotherapeutics, 2023 - Elsevier
Restless legs syndrome (RLS) is a sensorimotor disorder that severely affects sleep. It is
characterized by an urge to move the legs, which is often accompanied by periodic limb …

Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome

AS Walters, Y Li, BB Koo, WG Ondo, LB Weinstock… - Brain, 2023 - academic.oup.com
Restless legs syndrome (RLS) is responsive to opioid, dopaminergic, and iron-based
treatments. Receptor blocker studies in RLS patients suggest that the therapeutic efficacy of …

Association of low serum ferritin levels with augmentation in patients with restless legs syndrome: A systematic review and meta-analysis

YS Li, WC Yeh, CY Hsu - Sleep Medicine, 2023 - Elsevier
Background Augmentation of restless legs syndrome (RLS) is an iatrogenic side effect
induced by dopaminergic agents, and it is a major cause of therapeutic failure. Iron …

Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis

MP Mogavero, M Salemi, G Lanza, A Rinaldi… - IScience, 2024 - cell.com
The aim of this study was to analyze signaling pathways associated with differentially
expressed messenger RNAs in people with restless legs syndrome (RLS). Seventeen RLS …

Circadian rhythm in restless legs syndrome

M Tang, Q Sun, Y Zhang, H Li, D Wang, Y Wang… - Frontiers in …, 2023 - frontiersin.org
Restless legs syndrome (RLS) is a sensorimotor disorder with a obvious circadian rhythm,
as its symptoms often occur or worsen only in the evening or at night. The mechanisms …

Why cells need iron: a compendium of iron utilisation

MR Teh, AE Armitage, H Drakesmith - Trends in Endocrinology & …, 2024 - cell.com
Iron deficiency is globally prevalent, causing an array of developmental, haematological,
immunological, neurological, and cardiometabolic impairments, and is associated with …